Jacob Robinson
@JTRobinsonLab
co-founder & CEO @motifneuro | Prof. at Rice. | Neurotech & Hydra enthusiast. Girl dad. Making tiny things to stimulate and record brain activity. Views my own.
Are we headed toward a technology revolution in therapeutic BCI? I just wrote this piece about why I believe neurotech will become an indispensable tool for addressing the growing mental health crisis and become as common as personal computing. 🧵 open.substack.com/pub/brainjacob… #BCI

Happy Father’s Day to all you fellow Dads out there hatching your master plan…

Totally blown away by the experience of presenting at MARS: Fascinating dinners with @JeffBezos, Ron Howard, wonderful founders, scientists, and folks from Amazon. I even got to fan-boy over my favorite podcasters Ben Gilbert and David Rosenthal (who were super kind BTW). Most…




Biotech Launch Pad Fellows: A winning formula | Giving | @RiceUniversity @RiceLaunchPad giving.rice.edu/biotech-launch…
Just a reminder that the abstract submission deadline for InterfaceNeuro is coming up on March 14. Submit your work and come join us for this interdisciplinary meeting!
I’m inviting you to attend a conference May 7-8 at Georgia Tech called InterfaceNeuro (interfaceneuro.org), targeting the intersection of neuroscience, neuroengineering, clinical/translational research, neurotech industry, and individuals with lived experiences. Please RT!
We're thrilled to formally welcome Joshua Woods, PhD as our Senior Electrical Engineer! Josh has been integral in our world for some time now. His doctoral work at @JTRobinsonLab @RiceUniversity included pioneering the first DOT and magnetoelectric power for neural networks.
We're honored to be selected by @ARIA_research for a multimillion-dollar award through their Precision Neurotechnologies Program. This funding will accelerate the development of our therapeutic Brain-Computer Interface to treat mood, attention, and sleep disorders 🧠🚀
🚨I’m super excited to announce the teams we’re funding as part of our Precision Neurotechnologies programme.🚨 They’ll work on the next-gen tech that’ll allow us to understand + treat a wider range of brain disorders than ever before. Read more below (1/3)
We’re excited to announce the 18 teams we’re funding in Precision Neurotechnologies 🧠 They’ll work to unlock new ways to interface with the brain at the neural circuit level, with unprecedented precision. (1/3)
We've been selected by @ARIA_research to develop a network of neural devices designed to monitor and regulate mental and cognitive states without brain surgery. The UK-based program led by @JacquesCarolan is contributing £69M to unlock the full potential of #neurotech.
We’re excited to announce the 18 teams we’re funding in Precision Neurotechnologies 🧠 They’ll work to unlock new ways to interface with the brain at the neural circuit level, with unprecedented precision. (1/3)
Just out @natrevbioeng, check out our perspective on integrating bioelectronics with cell-based synthetic biology. Shout out to this awesome crew: @veiseho, Tzahi Cohen-Karni, @DrRituRaman, @GallowayLabMIT, @JTRobinsonLab, and Christian Schreib nature.com/articles/s4422… 🧵1/7
Intriguing read by @JTRobinsonLab and @SumnerLN. While broadening the definition of BCI may be controversial, it encourages developers to expand their perspective and learn from existing technologies. nature.com/articles/s4155…
My rationale for our controversial comment in Nature BME proposing an application-based taxonomy for BCI (unrolled from LinkedIn): Why we should consider labeling BCI based on its intended use. substack.com/inbox/post/154…
Can you think of a more controversial Christmas dinner topic than "What is a BCI?" Today in @NatBME, we propose an application-based taxonomy -> Clearer language for patients, regulators, and innovators alike. Proud to collaborate with @JTRobinsonLab and an incredible team! 🎁
Heading to the icon’s last show tomorrow in Vancouver and feeling E22. IYKYK 🫶 #ErasTourVancouver

Come see @emilychangtv discuss the future of BCI with @motifneuro, @synchroninc, and others. Spoilers: a certain Nobel Laureate and “god father of AI” comes out as a potential BCI adopter, and our very own Jon Nelson makes someone cry.. (as usual!)
Neurotech startup Motif says it has built a pea-sized brain chip that can treat mental illnesses, including depression, without the side effects of conventional drugs. More about the power of brain-computer interfaces on Posthuman with @emilychangtv trib.al/4QCX0FG